2-(5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-YL)ethanamine(CAS: 1017346-04-1)

2-(5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-YL)ethanamine (CAS: 1017346-04-1) falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and must comply with REACH regulations in the European Union. In the United States, it may also be subject to FDA and EPA guidelines for handling and disposal. Companies should consult the latest regulatory updates and maintain proper documentation for storage and transportation.

Alternatives to 2-(5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-YL)ethanamine (CAS: 1017346-04-1) include analogs with different substituents, such as 2-(5-(3-Fluorophenyl)-1,3,4-oxadiazol-2-YL)ethanamine. Other synthetic approaches involve using alternative reagents like 4-fluorophenyl isocyanate in place of 4-fluorophenyl oxadiazole, which can lead to similar compounds with varying properties.

The market for 2-(5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-YL)ethanamine (CAS: 1017346-04-1) has seen steady demand, particularly in pharmaceuticals and materials science. Research trends focus on its potential as a drug candidate and as a building block for organic synthesis. Emerging studies are exploring its use in antibacterial and antiviral applications, which could drive further market growth.

Waste containing 2-(5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-YL)ethanamine (CAS: 1017346-04-1) should be collected in appropriate containers and stored separately. Incineration is a common disposal method, but professional waste disposal services should be used for large quantities or hazardous waste. Environmental precautions include proper labeling, minimizing spillage, and adhering to local and international environmental protection standards.